Status:
RECRUITING
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This research trial studies germ-line mutations in blood and saliva samples from patients with cancer. Studying samples of blood and saliva from patients with cancer in the laboratory may help doctors...
Detailed Description
PRIMARY OBJECTIVES: I. To collect germ-line deoxyribonucleic acid (DNA) and nucleic acids from cancer patients to further investigate the association and identify new germ-line mutations that impact ...
Eligibility Criteria
Inclusion
- Pathologically or clinical confirmed tissue diagnosis of a cancer
- Ability to understand and the willingness to sign a written informed consent
Exclusion
- Patients will be excluded if their cancer cannot be confirmed
- Refusal to sign the informed consent
Key Trial Info
Start Date :
September 16 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 16 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT02280161
Start Date
September 16 2014
End Date
September 16 2027
Last Update
November 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jonsson Comprehensive Cancer Center
Los Angeles, California, United States, 90095